abrdn Life Sciences Investors
HQL
55 hedge funds and large institutions have $60.1M invested in abrdn Life Sciences Investors in 2017 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 24 increasing their positions, 13 reducing their positions, and 6 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
85% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 13
50% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 6
6% more funds holding
Funds holding: 52 → 55 (+3)
1.73% more ownership
Funds ownership: 12.71% → 14.44% (+1.7%)
4% more capital invested
Capital invested by funds: $57.9M → $60.1M (+$2.17M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$2.82M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$1.2M |
| 3 |
Cohen & Steers
New York
|
+$1.09M |
| 4 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
+$378K |
| 5 |
DA
Doliver Advisors
Houston,
Texas
|
+$357K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
William Blair & Company
Chicago,
Illinois
|
-$1.2M |
| 2 |
SI
Stephens Inc
Little Rock,
Arkansas
|
-$1.1M |
| 3 |
Morgan Stanley
New York
|
-$504K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$475K |
| 5 |
NIM
Needham Investment Management
New York
|
-$212K |
HQL Hedge Fund Activity: Q4 2017 in Review
55 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q4 2017, worth a combined $60.1M — up 3.8% from $57.9M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new HQL positions and 6 closed out — a net gain of 3 holders — while 24 added to existing stakes and 13 trimmed.
The largest buyer was Raymond James & Associates, adding an estimated $2.82M. The largest seller was William Blair & Company, exiting entirely with an estimated $1.2M sold.
- 55 institutional investors held abrdn Life Sciences Investors (HQL) as of Q4 2017, up from 52 in Q3 2017.
- Funds reported $60.1M of abrdn Life Sciences Investors stock for Q4 2017, up 3.8% quarter-over-quarter.
- 9 funds opened new abrdn Life Sciences Investors positions in Q4 2017 and 6 closed out, a net change of +3 holders.
- The largest abrdn Life Sciences Investors buyer in Q4 2017 was Raymond James & Associates, an estimated $2.82M added.
- The largest abrdn Life Sciences Investors seller in Q4 2017 was William Blair & Company, an estimated $1.2M sold.
Based on aggregated 13F filings for Q4 2017.